Penumbra
PEN
#1836
Rank
A$13.78 B
Marketcap
$359.07
Share price
1.45%
Change (1 day)
24.23%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Penumbra (PEN) - Total debt

Total debt on the balance sheet as of September 2024 : A$0.34 Billion

According to Penumbra's latest financial reports the company's total debt is A$0.34 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Penumbra - Total debt on balance sheet (from 2018 to 2024)

Total debt by year

Year Total debt Change
2023-12-31A$0.34 B-0.72%
2022-12-31A$0.34 B44.73%
2021-12-31A$0.23 B138.19%
2020-12-31A$0.10 B-14.5%
2019-12-31A$0.11 B
2018-12-31N/A
2013-12-31A$6.72 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
A$49.69 M-85.56%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.24 B 261.35%๐Ÿ‡บ๐Ÿ‡ธ USA